Neuroprotective Products Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Neuroprotective Products Market to 2027 - Global Analysis and Forecasts by Type (Cholinesterase inhibitors, NMDA receptor antagonists, Others); Application (Alzheimer's disease, Multiple Sclerosis, Others.)

Report Code: TIPRE00003826 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
MARKET INTRODUCTION
Neuroprotective Products are medications that are used to protect the brain neurons from degeneration and injuries. These are used to treat several complications such as Parkinson's disease, Alzheimer's diseases and traumatic brain injuries.

MARKET DYNAMICS
The Neuroprotective Products Market is anticipated to grow in the forecast period owing to driving factors such as increasing demand for neuroprotectives, increasing average life span of people, rising incidence of neurogenerative diseases, increasing population of geriatric population, increasing need for brain injury treatment caused mainly by road accidents. Nevertheless, the high cost involved in the R&D, stringent regulatory approvals and high failure rate of majority of prospective drugs in clinical trials may hamper the market growth in the forecast period.

MARKET SCOPE
The "Global Neuroprotective Products Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Neuroprotective Products market with detailed market segmentation by Type, Application and geography. The global Neuroprotective Products market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Neuroprotective Products market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Neuroprotective Products market is segmented on the basis Types and Application. Based on Drug Type the market is segmented into Cholinesterase inhibitors, NMDA receptor antagonists and others. Based on Application the market is segmented into Alzheimer's disease, Multiple Sclerosis and Others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Neuroprotective Products market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Neuroprotective Products market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Neuroprotective Products market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Neuroprotective Products market in these regions.

MARKET PLAYERS
The reports cover key developments in the Neuroprotective Products Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Neuroprotective Products Market are anticipated to lucrative growth opportunities in the future with the rising demand for Neuroprotective Products in the global market. Below mentioned is the list of few companies engaged in the Neuroprotective Products market.

The report also includes the profiles of key Neuroprotective Products market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • F. Hoffmann-La Roche AG
  • Eli Lilly and Company
  • Daiichi Sankyo Company
  • Allergan plc
  • Novartis AG
  • AstraZeneca plc
  • Dr. Reddy's Laboratories Ltd
  • Astrocyte Pharmaceuticals, Inc
  • Teva Pharmaceutical Industries Ltd
  • Biogen Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Neuroprotective Products Market - By Type
1.3.2 Neuroprotective Products Market - By Application
1.3.3 Neuroprotective Products Market - By Region
1.3.3.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. NEUROPROTECTIVE PRODUCTS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. NEUROPROTECTIVE PRODUCTS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. NEUROPROTECTIVE PRODUCTS MARKET - GLOBAL MARKET ANALYSIS
6.1. NEUROPROTECTIVE PRODUCTS - GLOBAL MARKET OVERVIEW
6.2. NEUROPROTECTIVE PRODUCTS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. NEUROPROTECTIVE PRODUCTS MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. CHOLINESTERASE INHIBITORS
7.3.1. Overview
7.3.2. Cholinesterase inhibitors Market Forecast and Analysis
7.4. NMDA RECEPTOR ANTAGONISTS
7.4.1. Overview
7.4.2. NMDA receptor antagonists Market Forecast and Analysis
7.5. OTHERS
7.5.1. Overview
7.5.2. Others Market Forecast and Analysis
8. NEUROPROTECTIVE PRODUCTS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. ALZHEIMER'S DISEASE
8.3.1. Overview
8.3.2. Alzheimer's disease Market Forecast and Analysis
8.4. MULTIPLE SCLEROSIS
8.4.1. Overview
8.4.2. Multiple Sclerosis Market Forecast and Analysis
8.5. OTHERS.
8.5.1. Overview
8.5.2. Others. Market Forecast and Analysis
9. NEUROPROTECTIVE PRODUCTS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Neuroprotective Products Market Overview
9.1.2 North America Neuroprotective Products Market Forecasts and Analysis
9.1.3 North America Neuroprotective Products Market Forecasts and Analysis - By Type
9.1.4 North America Neuroprotective Products Market Forecasts and Analysis - By Application
9.1.5 North America Neuroprotective Products Market Forecasts and Analysis - By Countries
9.1.5.1 United States Neuroprotective Products Market
9.1.5.1.1 United States Neuroprotective Products Market by Type
9.1.5.1.2 United States Neuroprotective Products Market by Application
9.1.5.2 Canada Neuroprotective Products Market
9.1.5.2.1 Canada Neuroprotective Products Market by Type
9.1.5.2.2 Canada Neuroprotective Products Market by Application
9.1.5.3 Mexico Neuroprotective Products Market
9.1.5.3.1 Mexico Neuroprotective Products Market by Type
9.1.5.3.2 Mexico Neuroprotective Products Market by Application
9.1.5.4 US Neuroprotective Products Market
9.1.5.4.1 US Neuroprotective Products Market by Type
9.1.5.4.2 US Neuroprotective Products Market by Application
9.2. EUROPE
9.2.1 Europe Neuroprotective Products Market Overview
9.2.2 Europe Neuroprotective Products Market Forecasts and Analysis
9.2.3 Europe Neuroprotective Products Market Forecasts and Analysis - By Type
9.2.4 Europe Neuroprotective Products Market Forecasts and Analysis - By Application
9.2.5 Europe Neuroprotective Products Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Neuroprotective Products Market
9.2.5.1.1 Germany Neuroprotective Products Market by Type
9.2.5.1.2 Germany Neuroprotective Products Market by Application
9.2.5.2 France Neuroprotective Products Market
9.2.5.2.1 France Neuroprotective Products Market by Type
9.2.5.2.2 France Neuroprotective Products Market by Application
9.2.5.3 Italy Neuroprotective Products Market
9.2.5.3.1 Italy Neuroprotective Products Market by Type
9.2.5.3.2 Italy Neuroprotective Products Market by Application
9.2.5.4 Spain Neuroprotective Products Market
9.2.5.4.1 Spain Neuroprotective Products Market by Type
9.2.5.4.2 Spain Neuroprotective Products Market by Application
9.2.5.5 United Kingdom Neuroprotective Products Market
9.2.5.5.1 United Kingdom Neuroprotective Products Market by Type
9.2.5.5.2 United Kingdom Neuroprotective Products Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Neuroprotective Products Market Overview
9.3.2 Asia-Pacific Neuroprotective Products Market Forecasts and Analysis
9.3.3 Asia-Pacific Neuroprotective Products Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Neuroprotective Products Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Neuroprotective Products Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Neuroprotective Products Market
9.3.5.1.1 Australia Neuroprotective Products Market by Type
9.3.5.1.2 Australia Neuroprotective Products Market by Application
9.3.5.2 China Neuroprotective Products Market
9.3.5.2.1 China Neuroprotective Products Market by Type
9.3.5.2.2 China Neuroprotective Products Market by Application
9.3.5.3 India Neuroprotective Products Market
9.3.5.3.1 India Neuroprotective Products Market by Type
9.3.5.3.2 India Neuroprotective Products Market by Application
9.3.5.4 Japan Neuroprotective Products Market
9.3.5.4.1 Japan Neuroprotective Products Market by Type
9.3.5.4.2 Japan Neuroprotective Products Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Neuroprotective Products Market Overview
9.4.2 Middle East and Africa Neuroprotective Products Market Forecasts and Analysis
9.4.3 Middle East and Africa Neuroprotective Products Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Neuroprotective Products Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Neuroprotective Products Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Neuroprotective Products Market
9.4.5.1.1 South Africa Neuroprotective Products Market by Type
9.4.5.1.2 South Africa Neuroprotective Products Market by Application
9.4.5.2 Saudi Arabia Neuroprotective Products Market
9.4.5.2.1 Saudi Arabia Neuroprotective Products Market by Type
9.4.5.2.2 Saudi Arabia Neuroprotective Products Market by Application
9.4.5.3 U.A.E Neuroprotective Products Market
9.4.5.3.1 U.A.E Neuroprotective Products Market by Type
9.4.5.3.2 U.A.E Neuroprotective Products Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Neuroprotective Products Market Overview
9.5.2 South and Central America Neuroprotective Products Market Forecasts and Analysis
9.5.3 South and Central America Neuroprotective Products Market Forecasts and Analysis - By Type
9.5.4 South and Central America Neuroprotective Products Market Forecasts and Analysis - By Application
9.5.5 South and Central America Neuroprotective Products Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Neuroprotective Products Market
9.5.5.1.1 Brazil Neuroprotective Products Market by Type
9.5.5.1.2 Brazil Neuroprotective Products Market by Application
9.5.5.2 Argentina Neuroprotective Products Market
9.5.5.2.1 Argentina Neuroprotective Products Market by Type
9.5.5.2.2 Argentina Neuroprotective Products Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. NEUROPROTECTIVE PRODUCTS MARKET, KEY COMPANY PROFILES
11.1. F. HOFFMANN-LA ROCHE LTD
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ELI LILLY AND COMPANY
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. DAIICHI SANKYO COMPANY, LIMITED
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. ALLERGAN
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. NOVARTIS AG
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. ASTRAZENECA
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. DR. REDDY'S LABORATORIES LTD
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. ASTROCYTE PHARMACEUTICALS, INC
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. TEVA PHARMACEUTICAL INDUSTRIES LTD
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. BIOGEN
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

- F. Hoffmann-La Roche AG
- Eli Lilly and Company
- Daiichi Sankyo Company
- Allergan plc
- Novartis AG
- AstraZeneca plc
- Dr. Reddy's Laboratories Ltd
- Astrocyte Pharmaceuticals, Inc
- Teva Pharmaceutical Industries Ltd
- Biogen Inc.
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book